Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

JF Garvey, CT Taylor… - European Respiratory …, 2009 - Eur Respiratory Soc
There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation.

JF Garvey, CT Taylor, WT McNicholas - The European Respiratory …, 2009 - europepmc.org
There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

[PDF][PDF] Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

JF Garvey, CT Taylor, WT McNicholas - EUROPEAN RESPIRATORY …, 2009 - qdcxjkg.com
There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

[PDF][PDF] Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

JF Garvey, CT Taylor… - EUROPEAN …, 2009 - researchgate.net
There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

[引用][C] Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

JF GARVEY, CT TAYLOR… - The European …, 2009 - pascal-francis.inist.fr
Cardiovascular disease in obstructive sleep apnoea syndrome : the role of intermittent
hypoxia and inflammation CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation.

JF Garvey, CT Taylor, WT McNicholas - lenus.ie
There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

JF Garvey, CT Taylor… - The European …, 2009 - pubmed.ncbi.nlm.nih.gov
There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

[PDF][PDF] Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

JF Garvey, CT Taylor, WT McNicholas - EUROPEAN RESPIRATORY …, 2009 - qdcxjkg.com
There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

[引用][C] Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation

JF Garvey, CT Taylor, WT McNicholas - European Respiratory Journal, 2009 - cir.nii.ac.jp
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia
and inflammation | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …